Page last updated: 2024-09-04

salicylideneaniline and beta-thujaplicin

salicylideneaniline has been researched along with beta-thujaplicin in 1 studies

Compound Research Comparison

Studies
(salicylideneaniline)
Trials
(salicylideneaniline)
Recent Studies (post-2010)
(salicylideneaniline)
Studies
(beta-thujaplicin)
Trials
(beta-thujaplicin)
Recent Studies (post-2010) (beta-thujaplicin)
23015205399

Protein Interaction Comparison

ProteinTaxonomysalicylideneaniline (IC50)beta-thujaplicin (IC50)
E3 ubiquitin-protein ligase Mdm2 isoform aHomo sapiens (human)3.58
protein Mdm4 isoform 1Homo sapiens (human)3.58
Polyphenol oxidase 2Agaricus bisporus0.09
Carboxypeptidase A1Bos taurus (cattle)2.76
TyrosinaseHomo sapiens (human)8.98
Breast cancer type 1 susceptibility proteinHomo sapiens (human)3.89
BRCA1-associated RING domain protein 1Homo sapiens (human)3.89

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jung, SH; Manickam, M; Namasivayam, V; Pillaiyar, T1

Reviews

1 review(s) available for salicylideneaniline and beta-thujaplicin

ArticleYear
Inhibitors of Melanogenesis: An Updated Review.
    Journal of medicinal chemistry, 2018, 09-13, Volume: 61, Issue:17

    Topics: alpha-MSH; Biphenyl Compounds; Crystallization; Enzyme Inhibitors; Humans; Melanins; Monophenol Monooxygenase; Peptidomimetics; Radiation, Ionizing; Resveratrol; Signal Transduction; Skin

2018